PRMT5 and cancer: The developing evidence suggests that methylation plays a crucial role in cancer development [10], and type II protein arginine methyltransferase 5 (PRMT5) can methylate histone or non-histone protein to govern RNA processing, chromatin stability, cell proliferation, survival, cell metabolism, and cancers, which is emerging as an attractive therapeutic target recently [11, 12].